NIH-funded research R15 grant

Exploring how specific proteins affect pain sensitivity in fruit flies.

Official title: Investigation of Armadillo/ß-catenin Mechanisms Influencing Nociceptive Sensitivity in Drosophila

Funded at University of New England · NIH-10653377 · Data updated 2026-11-12

This study is looking at how a protein in fruit flies affects their response to pain, and by understanding this, researchers hope to find new ways to help people who experience unusual pain.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of New England
NIH-funded
Lab location1 site (Biddeford, United States)
Project startAugust 1, 2023
Project endJuly 31, 2026
Funding year2023
Award (this year)$426,000
NIH project number1R15NS131952-01
Project IDNIH-10653377 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include individuals suffering from chronic pain conditions who are seeking alternative pain management options.

Less likely to help

Patients with acute pain conditions or those who do not respond to genetic-based therapies may not benefit from this research.

What this research studies

This research investigates the mechanisms by which a protein called Armadillo, related to ß-catenin, influences how fruit flies respond to painful stimuli. By using genetic techniques, the researchers will manipulate the expression of this protein in specific nerve cells of the flies to observe changes in their pain sensitivity. The findings aim to uncover new targets for pain medications that could lead to better treatments for abnormal pain in humans.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective pain management therapies with fewer side effects than current opioid treatments.

How similar studies have gone: Other research has shown success in using genetic models like Drosophila to identify pain mechanisms, suggesting this approach has potential for meaningful discoveries.

Where this research is happening

  • University of New England
    Biddeford, United States
    Active

Researchers

  • Principal investigator: Ganter, Geoffrey — University of New England
  • Study coordinator: Ganter, Geoffrey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.